Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections
First hospital in
Every year, 350,000 patients contract bloodstream infections in
AdvanDx’s PNA FISH tests employ unique technology that detects bacteria’s genetic material to provide identification results in just over 2 hours. “The fast tests will enable the microbiology lab to provide results 1 to 3 days sooner than conventional methods for such serious pathogens as Staphylococcus aureus, Candida albicans and Candida glabrata,” said
Clinical trials conducted at hospitals in
“We are very excited to implement the latest diagnostic tool to help our clinicians identify these serious infections in our critically ill patients,” said.
About Memorial Health
Memorial Health is a two-state healthcare organization serving a 35-county area in southeast
About Bloodstream Infections
Every year, 350,000 patients contract bloodstream infections, causing over 90,000 unnecessary deaths and significant costs to the healthcare system. The infection is detected when a culture of the patient’s blood (i.e. a blood culture) turns positive with bacteria and yeast. Rapid and accurate identification of the specific infecting pathogen is crucial to ensure early and appropriate therapy and save patient lives.
About PNA FISH(R)
PNA FISH is an easy-to-use and highly sensitive and specific fluorescence in situ hybridization (FISH) assay that uses PNA (peptide nucleic acid) probes to target species specific ribosomal RNA (rRNA) in live bacteria and yeast. PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical studies show that rapid identification of bloodstream pathogens using PNA FISH tests leads to more appropriate patient therapy that saves lives and reduces unnecessary antibiotic use, patient length of stay and hospital costs.
References: (1)Forrest et al. Antimicrob Agents Chemother. 2008 Oct;52(10):3558-63. (2) Shoham et al. Ther Clin Risk Manag. 2008 Jun;4(3):637-40. (3) Forrest et al. J Antimicrob Chemother. 2006 Jul;58(1):154-8.